Introduction
Several characteristics of rabbits make it a more appropriate species than mice for the study of lipoprotein metabolism and atherosclerosis susceptibility. 1 In contrast to mouse apolipoprotein (apo) B mRNA, rabbit apo B mRNA is not edited in the liver 2 leading to the production of apo B-100 containing very low-density lipoproteins similar as in humans. Rabbits, like humans, synthesize cholesteryl ester transfer protein, 3 which transfers cholesteryl esters from high-density lipoproteins (HDL) to very low-density lipoproteins and chylomicrons and plays a central role in remodelling of HDL. Therefore, rabbit models of atherosclerosis, such as the Watanabe Heritable Hyperlipidemic Rabbit, are better suited than murine models to evaluate gene transfer for prevention and treatment of atherosclerotic vascular diseases. An intriguing feature of lipoprotein metabolism in some rabbit strains, such as New Zealand White rabbits, is their high susceptibility to diet-induced hypercholesterolemia, whereas other strains, such as Dutch Belt rabbits, are resistant to diet-induced hypercholesterolemia. 4 This difference has been attributed to delayed chylomicron remnant clearance caused by small diameters of sinusoidal fenestrae, 5 but this hypothesis has not been formally proven. Small fenestrae may constitute a barrier for hepatocyte-directed adenoviral gene transfer.
Previous studies on adenoviral gene transfer in rabbits have been performed with E1-deleted vectors containing expression cassettes driven by the ubiquitously active cytomegalovirus [6] [7] [8] [9] or Rous Sarcoma Virus promoter, 10 which do not allow accurate assessment of transgene expression by hepatocytes, since these promoters are active in different organs and in the three main cell types constituting the liver: hepatocytes (consider: parenchymal cells), Kupffer cells and sinusoidal endothelial cells. The 1.5 kb human a 1 -antitrypsin promoter does not contain upstream sequences for expression in macrophages 11 and is strictly hepatocyte specific. The combination of the human a 1 -antitrypsin promoter and several copies of the hepatocyte specific human apo E enhancer 12 forms a powerful expression cassette for hepatocyte specific overexpression of transgenes after retroviral, adenoviral or adeno-associated viral gene transfer. [13] [14] [15] [16] To evaluate the determinants of hepatocyte transduction by adenoviral vectors in rabbits and to test the hypothesis that the size of sinusoidal fenestrae affects hepatocyte transduction, gene transfer using human apo A-I as a marker gene was performed in three rabbit strains with E1E3E4-deleted vectors containing the hepatocyte specific 1.5 kb human a 1 -antitrypsin promoter upstream of the genomic human apo A-I sequence and four copies of the human apo E enhancer. The effect of pharmacological modulation of the size of sinusoidal fenestrae on hepatocyte transduction was evaluated.
Results
Genetic background has a major impact on human apo A-I expression and intrahepatic transgene DNA distribution after intravenous adenoviral gene transfer in rabbits Figure 1 illustrates human apo A-I expression after marginal ear vein transfer (MVT) with 4 Â 10 12 particles/ kg of AdAT 4 in New Zealand White (NZW), Fauve de Bourgogne (FDB) and Dutch Belt (DB) rabbits. The E1E3E4-deleted vector AdAT 4 contains the 1.5 kb hepatocyte specific human a 1 -antitrypsin promoter upstream of the genomic human apo A-I sequence and four copies of the human apo E enhancer. Human apo A-I expression level was 4779.5 mg/dl at day 7 after MVT in DB rabbits and was below 1 mg/dl in NZW and FDB rabbits. The area under the curve (AUC) of human apo A-I levels from day 0 till day 10 after MVT (Table 1) was 95-fold (Po0.01) and 220-fold (Po0.01) higher in DB rabbits than in NZW and FDB rabbits, respectively. To evaluate whether the effect of genetic background on human apo A-I levels correlates with differences in human apo A-I transgene DNA copy number in the liver, quantitative real time PCR was performed. Human apo A-I transgene DNA copy number data in the liver at day 14 after intravenous transfer are shown in Table 2 . Compared to Dutch Belt rabbits, the human apo A-I transgene DNA copy number in the liver per diploid genome was 3.1-fold (Po0.01) lower in NZW rabbits and not significantly different in FDB rabbits, indicating that differences between transgene DNA copy numbers in the liver cannot account for the dramatic differences in expression levels. As the liver contains hepatocytes on the one hand and sinusoidal cells on the other hand, transgene DNA copy number in liver tissue may substantially differ from transgene DNA copy number in hepatocytes. Since the 1.5 kb human a 1 -antitrypsin promoter is strictly hepatocyte specific, human apo A-I mRNA levels in the liver after transfer with AdAT 4 correlate with human apo A-I transgene DNA in hepatocytes. The human apo A-I mRNA/DNA ratio in the liver correlates therefore with the ratio of transgene DNA in hepatocytes versus transgene DNA in total liver. Human apo A-I mRNA/ DNA ratios are reported in Table 3 . This ratio was 1.670.37 at day 14 after MVT in Dutch Belt rabbits and was 77-fold (Po0.01) and 69-fold (Po0.01) higher than in NZW and FDB rabbits, respectively, indicating that the genetic background affects intrahepatic transgene DNA distribution. Determination of the coxsackie-adenovirus receptor (CAR) and a v -integrin mRNA levels in the liver by real-time RT-PCR did not show significant differences between the three rabbit strains (Table 4) . As CAR protein on the cell surface has been shown to positively correlate with CAR mRNA expression 17 and since the level of a v -integrin mRNA closely correlates with a v b 3 -and a v b 5 -integrins at the protein level, 18 significant Intraportal gene transfer preceded by intraportal injection of sodium decanoate dramatically increases human apo A-I expression in NZW and FDB, but not in DB rabbits
Human apo A-I expression after intraportal gene transfer (IPT) in NZW, FDB and DB rabbits is illustrated in Figure  3a . The AUC of human apo A-I levels between day 0 and day 10 ( Table 1) after IPT was 10-fold (Po0.01) and 4.8-fold (Po0.01) higher in DB rabbits compared to NZW and FDB rabbits, respectively. In comparison with MVT, IPT induced 10-fold (Po0.01) and 51-fold (Po0.01) higher human apo A-I levels from day 0 till day 10 after transfer in NZW and FDB rabbits, respectively (Table 1) , whereas no effect was observed in DB rabbits. Figure 3b shows human apo A-I expression after IPT preceded by intraportal injection of 0.3 mmol/kg of sodium decanoate (IPTSD). The AUC of human apo A-I levels in NZW rabbits was 32-fold (Po0.01) and 3.2-fold (Po0.05) higher after IPTSD than after MVT and IPT, respectively (Table 1) . In FDB rabbits, the AUC of human apo A-I levels from day 0 till day 10 after IPTSD in FDB rabbits was 120-fold (Po0.01) and 2.4-fold (Po0.05) higher than after MVT and IPT, respectively. Human apo A-I expression in DB rabbits was not significantly altered after IPTSD compared to MVT or IPT. Intraportal injection of 0.3 mmol/kg of sodium decanoate increased the size of sinusoidal fenestrae in New Zealand White rabbits from 10871.3 to 12373.4 nm (Po0.01), providing evidence that the increase of human apo A-I expression induced by sodium decanoate, is mediated by its effect on the size of sinusoidal fenestrae.
To extend the observations with IPTSD, IPT was preceded by intraportal injection of 0.0375 mmol/kg of Sinusoidal fenestrae size in hepatocyte transduction J Lievens et al n-dodecyl b-D-maltoside in NZW rabbits. Human apo A-I levels were similar compared to IPTSD (data not shown). The AUC of human apo A-I levels from day 0 till day 10 (170722 mg days/dl) was 46-fold (Po0.01) and 4.6-fold (Po0.01) higher than after MVT and IPT, respectively.
Strain dependence of the effect of the route and mode of gene transfer on intrahepatic transgene DNA distribution is consistent with the presence of an anatomical barrier in NZW and FDB rabbits, but not in DB rabbits
The route and mode of gene transfer had no significant effect on human apo A-I transgene DNA copy number in each strain ( Table 2) . Quantification of transgene DNA in the lung, heart, kidney and spleen indicated that the route of administration and sodium decanoate or n-dodecyl b-D-maltoside had no significant effect on the biodistribution of adenoviral vectors in each strain. Route and mode of gene transfer were significant determinants of the human apo A-I mRNA/DNA ratio at day 14 after transfer in NZW and FDB rabbits, but not in DB rabbits (Table 3) , consistent with the presence of an anatomical barrier in the former two strains but not in the latter one. To exclude that these observations were confounded by an immune response against human apo A-I at day 14 (see below), human apo A-I transgene DNA levels per diploid genome (Figure 4a ), human apo A-I mRNA levels normalized to the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA levels ( Figure 4b ) and the human apo A-I mRNA/DNA ratio (Figure 4c ) in the liver were quantified at day 5 after MVT, IPT, and IPTSD in NZW rabbits. Figure 4a illustrates that at day 5 after transfer, when an adaptive immune response against human apo A-I is not yet established, no significant differences of human apo A-I transgene DNA copy numbers were observed. Compared to MVT, the human apo A-I mRNA/DNA ratio was 2.9-fold (Po0.05) and 25-fold (Po0.05) higher after IPT, IPTSD, respectively, confirming that route and mode of gene transfer are determinants of the intrahepatic transgene DNA distribution in NZW rabbits. To further corroborate the hypothesis that differences in intrahepatic distribution of transgene DNA underlie the effect of the mode of gene transfer on human apo A-I expression 
The Kupffer cell blocking agent GdCl 3 was administered at a dose of 10 mg/kg 24 h before transfer with 4 Â 10 12 particles/kg of AdAT 4 to NZW or FDB rabbits. This dose of GdCl 3 has been shown to reduce the clearance of colloidal carbon with 64% in rabbits. 19 The AUC of human apo A-I expression from day 0 till day 10 after MVT preceded by administration of GdCl 3 was 15-fold (8.078.0 mg days/dl; Po0.01) and 6.6-fold (29719 mg days/dl; Po0.05) lower in New Zealand White and Fauve de Bourgogne rabbits, respectively, than after IPTSD with the same dose, consistent with the concept that the small size of sinusoidal fenestrae is the primary cause of low transgene expression in these two strains. MVT with a dose of 8 Â 10 12 particles/kg resulted in human apo A-I expression levels, which were 2.5-fold lower (48715 mg.days/dl; Po0.05) and not significantly different (150737 mg.days/dl) than after IPTSD with 4 Â 10 12 particles/kg in New Zealand White and Fauve de Bourgogne rabbits, respectively.
Humoral immune response against human apo A-I accounts for the decline of human apo A-I levels after day 10
Human apo A-I levels decreased sharply between day 10 and day 14, irrespective of the mode of gene transfer and the strain (Figures 1 and 3a, b) . To evaluate whether the decrease of human apo A-I levels between day 10 and day 14 in the three rabbit strains was associated with a humoral immune response against human apo A-I, antibody titers were quantified by ELISA. The geometric means of the inverse of the titer at day 14 after MVT, IPT and IPTSD is shown in Table 5 . High titers of antibodies against human apo A-I were observed in all three strains. The causal role of anti-human apo A-I antibodies in the disappearance of human apo A-I protein in the plasma of several rabbits is indicated by the presence of significant amounts of human apo A-I mRNA in the liver of these rabbits at day 14 after transfer (data not shown). Data represent geometric means7standard error of the geometric mean of five different rabbits for each experimental condition.
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Discussion
The main findings of the present study are that (1) the smaller size of sinusoidal fenestrae in NZW and FDB rabbits compared to DB rabbits is a major obstacle for efficient transduction of hepatocytes by adenoviral vectors; (2) this impediment for hepatocyte directed gene transfer may be overcome by agents that increase the size of sinusoidal fenestrae; (3) immunological ignorance and tolerance for liver secreted xenogenic proteins after adenoviral gene transfer under control of hepatocyte specific promoters does not occur in rabbits, in contrast to mice. The liver sieve is formed by the fenestrated sinusoidal endothelium and separates the hepatic blood from the extracellular fluid in the space of Disse. 5 Previous studies using scanning electron microscopy have shown an average fenestral diameter of 89 nm in rats and 49 nm in rabbits. 20 To avoid artifactually reduced diameters during tissue preparation, 21 transmission electron microscopy of plastic-embedded specimens was used in the present investigation and not scanning electron microscopy of dried and thus shrunken specimens. Since the diameter of adenoviral particles determined by cryoelectron microscopy has been shown to be 110 nm, 22 the larger diameter of sinusoidal fenestrae in Dutch Belt rabbits (12473.4 nm) compared to New Zealand White (10871.3 nm) and Fauve de Bourgogne (10572.6 nm) rabbits is critical for smooth passage of adenoviral vectors through the sinusoidal wall to the space of Disse.
The demonstration that intraportal administration of sodium decanoate increases the diameter of sinusoidal fenestrae to 12373.4 nm in New Zealand White rabbits and enhances transgene expression in New Zealand White and Fauve de Bourgogne rabbits but not in Dutch Belt rabbits is consistent with the concept that the liver sieve is a limiting factor for gene transfer into hepatocytes in the former two strains, but not in the latter one. Pretreatment of airways with sodium decanoate has been demonstrated to increase b-galactosidase expression in the upper airways of mice by facilitating passage of vectors from the apical to the basolateral surface. 23 n-Dodecyl b-D-maltoside increases transport of drugs across Xenopus pulmonary membrane. 24 The effect of sodium decanoate on the size of sinusoidal fenestrae may be mediated by modulation of the fenestrae associated cytoskeleton, which has been shown to be involved in regulating the size of fenestrae. 25 Administration of the Kupffer cell blocking agent GdCl 3 or higher viral doses in New Zealand White and Fauve de Bourgogne rabbits only partially overcome the effect of the anatomical barrier constituted by the small fenestrae. A longer circulation time of adenoviral vectors secondary to reduced Kupffer cell phagocytosis or a higher vector dose will allow more vectors to penetrate into the space of Disse via fenestrae with a sufficient diameter for passage of adenoviral vectors.
Coxsackie-adenovirus receptor binding ablation 26, 27 and a v -integrin binding ablation 27, 28 do not significantly alter the biodistribution of adenoviral vectors in mice and monkeys, in contrast to ablation of heparan sulfate glycosaminoglycan binding. 29, 30 Besides the role of heparan sulfate glycosaminoglycans in hepatocyte transduction, anatomical vector barriers as a determinant of gene transfer into parenchymal cells and for biodistribution of vectors 31 should be considered. Liver fibrosis and cirrhosis lead to decreased number of fenestrae 32 and decreased transduction by adenoviral vectors has been observed in cirrhotic rat livers. 33 Also, capillarization and perisinusoidal fibrosis may lead to the development of a basal lamina, found to be absent in normal sinusoids. A significant reduction in the number of fenestrae and porosity of the sinusoidal lining wall was observed in alcoholic liver disease without cirrhosis 34 and in mouse hepatitis virus type 3 infection, 35 indicating that the liver sieve may be altered in several pathophysiological conditions. Aging is also associated with hepatic pseudocapillarization. [36] [37] [38] The size of fenestrae may also be a determinant of hepatocyte transduction after transfer with retroviral or lentiviral vectors, which have a diameter between 126 and 133 nm. [39] [40] [41] A role of the size of fenestrae in the biodistribution of adenoviral vectors in the adrenal gland has been previously suggested by Wang et al. 42 Systemic administration of adenoviral vectors in mice induced transgene expression in the adrenal gland that was comparable but somewhat lower than in the liver and predominant in the zona fasciculata, the part of the adrenal cortex with the largest diameter of fenestrae. However, a major difference between sinusoidal fenestrae and fenestrae in other organs is the presence of diaphragms in the latter. Differences in the size of sinusoidal fenestrae between different species have been recently reviewed. 43 Although data should be interpreted with caution because of procedural differences between different laboratories, the diameter in mice, rats and baboons was found to be at least 1.6-fold larger than in rabbits, whereas in sheep the diameter is similar as in rabbits. There is currently no reliable information on the size of fenestrae in humans and on genetic variation of this size. Determination of sinusoidal fenestrae size in humans will require surgical wedge biopsies in patients undergoing laparotomy and measurements with transmission electron microscopy.
We have previously demonstrated that human apo A-I gene transfer with AdAT 4 is associated with immunological ignorance and tolerance for human apo A-I in Balb/c mice 44 and in several other murine strains (unpublished data). Similarly, immunological tolerance for human factor IX in several murine strains has been demonstrated after adeno-associated viral gene transfer of a construct expressing human factor IX under control of the hepatic control region-1 and the human a 1 -antitrypsin promoter. 45 In contrast to our observations in mice, neutralizing antibodies against human apo A-I were observed in all three rabbit strains. Although lower expression levels in rabbits may impede development of tolerance for human apo A-I, immunological ignorance for human apo A-I has been observed in Balb/c mice after gene transfer with lower doses of AdAT 4 , which result in similar expression levels as in rabbits (unpublished data). Therefore, extrapolation of data on immunological unresponsiveness from murine to other species should be done cautiously. Use of autologous rabbit genes may be mandatory for long-term gene transfer in rabbits.
In conclusion, the present study demonstrates that the size of sinusoidal fenestrae is a critical determinant of hepatocyte transduction in rabbits. The existence of several pathophysiological conditions in which the liver Sinusoidal fenestrae size in hepatocyte transduction J Lievens et al sieve is altered underscores the relevance of this observation for the development of hepatocyte directed gene transfer.
Materials and methods

Generation of AdAT 4 and AdCMV
The construction and generation of the E1E3E4-deleted adenoviral vector AdAT 4 has been described previously.
15
AdAT 4 contains the human a 1 -antitrypsin promoter upstream of the genomic human apo A-I sequence and four copies of the human apo E enhancer. The E1-and E3-deletions extend from nucleotides 459 to 3327 and from nucleotides 28592 to 30470, respectively. The E4 deletion extends from nucleotides 32994 to 34998. The generation of the E1-deleted vector AdCMV, containing the 760 bp cytomegalovirus promoter upstream of the genomic human apo A-I sequence, has been published before. 46 Propagation and purification of vectors was performed as described previously.
47,48
Animal experiments To enhance endothelial permeability, sodium decanoate (Sigma-Aldrich, Steinheim, Germany) was administered by intraportal injection at a dose of 0.3 mmol/kg 10 min before gene transfer. Alternatively, n-dodecyl b-Dmaltoside (Sigma-Aldrich, Steinheim, Germany) was injected intraportally at a dose of 0.0375 mmol/kg.
To block Kupffer cell activity, GdCl 3 (Sigma-Aldrich) was administered at a dose of 10 mg/kg 24 h before transfer.
Human apo A-I ELISA
Human apo A-I levels were determined by sandwich ELISA as described previously. 46 Briefly, polystyrene microtiter plates (Elscolab, Kruisbeke, Belgium) were coated with the monoclonal antibodies A52C6/A58C9. Diluted plasma samples (1:1000; 1:2000; 1:4000; 1:8000) were added to the wells for 2 h. After washing, a 1:5000 dilution of the murine monoclonal antibody A 4 H 4 A 7 conjugated with peroxidase was added to the wells for 2 h. Peroxidase reaction was performed by adding H 2 O 2 and orthophenylenediamine. Finally, absorbance was measured at 492 nm. The sensitivity of this assay is 15.6 ng/ml.
Detection of anti-human apo A-I antibodies by ELISA
Human apo A-I antibodies were determined as described previously 49 with slight modifications. Briefly, polystyrene microtiter plates (Elscolab) were coated with 0.14 mM of human apo A-I (Biovalley, Paris, France). Dilutions of plasma samples up to 1:10 6 were added to the wells for 2 h. After washing the plates, pig anti-rabbit polyclonal antibodies conjugated with peroxidase (DAKO, Denmark) were diluted 1:5000 and added to the wells for 2 h. Peroxidase reaction was performed with H 2 O 2 and orthophenylenediamine and absorbance was measured at 492 nm. The titer of antibodies was defined as the plasma dilution for which the optical density of the antibody assay was higher than 0.100, which is significantly above background.
Quantification of human apo A-I transgene-DNA
Human apo A-I transgene DNA copy number per diploid genome was quantified using quantitative real-time PCR. The human apo A-I DNA copy number was normalized to the copy number of the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) housekeeping gene. The sequence of primers and probes for human apo A-I has been published before. 49 The rabbit GAPDH probe consisted of 5 0 CTG CCG CCT GGA GAA AGC TCG TAA 3
0 . The sequence of the GAPDH forward and reverse primer was 5 0 TGT CGG TCG TGG ACC TGA 3 0 and 5 0 CAC CAC CTT CTT GAT GTC GTC A 3 0 , respectively.
Quantification of human apo A-I mRNA in the liver
Total RNA was isolated from mouse liver using TRIzol Reagent (Life Technologies). RNA (10 mg) was treated with DNAse (Pharmacia, Roosendal, Netherlands) and subsequently reverse transcribed using Superscript II RT (Life Technologies) at 421C for 50 min in the presence of 0.5 mM dNTPs, 0.01 M DTT, 1 Â first-strand buffer and 250 ng pd(N) 6 Random Hexamer (Pharmacia). Human apo A-I cDNA was measured using quantitative real-time PCR and the human apo A-I cDNA copy number was normalized to the copy number of the GAPDH housekeeping gene.
Quantification of CAR and a v -integrin expression by real time RT-PCR
Probes and primers for rabbit CAR and rabbit a v -integrin were designed for target sequences that were identical in the three strains. The rabbit CAR probe, forward primer and reverse primer sequences consisted of 5 0 TGC TCA  TTG GTT GTA TCG TCT TTT GCT GTC Quantification of the size of sinusoidal fenestrae in the liver by transmission electron microscopy Perfusion of the liver with a fixative solution was performed essentially as described before in Wistar rats. 50, 51 After isoflurane anesthesia and exposure of the liver by laparotomy, the hepatic artery and common bile duct were clamped and two ligatures were placed around the portal vein. A 14 gauge needle was introduced in the portal vein and fixed by tightening the two ligatures. Perfusion was performed at a pressure of 15 cm H 2 O with 250-300 ml of 0.15 M cacodylate buffer at pH 7.4 and the inferior caval vein was transsected at the start of the perfusion. Subsequently, perfusion
Sinusoidal fenestrae size in hepatocyte transduction J Lievens et al fixation was performed with 250-300 ml of 1.5% glutaraldehyde fixative buffered in 0.067 M cacodylate at pH 7.4 until the color changed from dark reddish brown to yellow brown and the consistency from soft to rather stiff. The liver was removed and thin slices were cut with a razor blade into 1 mm 3 blocks, which were immediately transferred to a 1% OsO 4 fixative solution buffered with PBS 0.1 M pH 7.4 for subsequent immersion fixation for 1 h at 41C. Dehydration was carried out rapidly in graded ethanol series, followed by embedding in Epon. The specimens were examined in a Philips Tecnai 10 (Philips, Eindhoven, The Netherlands) at 100 kV as described before. 52 The average number of sinusoidal diameter measurements per rabbit was 450740.
For scanning electron microscopy, samples were treated as described 53 and examined in the Philips SEM 505 (Philips, Eindhoven, The Netherlands) at an accelerating voltage of 30 kV. The number of fenestrae per mm 2 was determined by analysing 20 sinusoids per rabbit.
PC and NPC isolation by collagenase perfusion and Nycodenz
s centrifugation PC and NPC were isolated using the method of Seglen 54 modified according to Nagelkerke et al 55 and further modified for cell isolations in rabbits. Briefly, a 16 G Braunule s (B Braun, Melsungen, Germany) was inserted in the portal vein and fixated with two silk 3.0 sutures. One vascular clamp was placed on the hepatic artery and the common bile duct and a second on the inferior caval vein between the renal veins and the hepatic veins. The outflow during perfusion was secured by transcardiac catherization of the inferior caval vein using a 1 ml Falcon s pipet, which was connected to a silicone tube. Preperfusion at a flow rate of 50 ml/min was performed with preperfusion buffer 54, 55 for 20 min. Collagenase (Sigma-Aldrich) buffer 54, 55 was perfused at a flow rate of 50 ml/min for 15 min using a closed circuit by connecting the outflow in the inferior caval vein via the silicone tube to the collagenase buffer reservoir. To determine transgene DNA and mRNA levels on whole liver tissue, a ligature was placed around the blood supply of one liver lobe before preperfusion. Subsequent steps were according to established protocols. 54 ,55 Nycodenz s was obtained from Lucron Bioproducts (De Pinte, Belgium).
Statistical analysis
Data are expressed as mean7standard error of the mean (s.e.m.). Antibody titers are expressed as geometric mean7standard error of the geometric mean. Comparison of human apo A-I levels or human apo A-I transgene DNA copy number were performed by nonparametric Mann-Whitney test using the INSTAT V2.05a statistical program (Graph Pad Software, San Diego, CA, USA). The AUC of human apo A-I levels was calculated by using NCSS 2000 (NCSS Statistical Software, Kaysville, Utah). The diameter of sinusoidal fenestrae of different strains was compared by one-way analysis of variance ANOVA followed by Tukey-Kramer Multiple Comparisons Test. A two-sided P-value of less than 0.05 was considered statistically significant.
